Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre la importancia, el cribado y la vacunación en pacientes con enfermedad inflamatoria intestinal

dc.contributor.authorFerreiro Iglesias, Rocío
dc.contributor.authorPiqueras, Marta
dc.contributor.authorRicart, Elena
dc.contributor.authorSempere, Laura
dc.contributor.authorRoca, Mariona
dc.contributor.authorMartín de Carpi, Javier
dc.contributor.authorBenítez, Olga
dc.contributor.authorZabana Abdo, Yamile
dc.contributor.authorMañosa, Míriam
dc.contributor.authorRodríguez Moranta, Francisco
dc.contributor.authorBarreiro de Acosta, Manuel
dc.contributor.authorGETECCU Spanish Group
dc.date.accessioned2023-01-13T18:29:27Z
dc.date.available2023-01-13T18:29:27Z
dc.date.issued2022-12-01
dc.date.updated2023-01-12T11:32:54Z
dc.description.abstractPatients with inflammatory bowel disease (IBD) may require different immunosuppressive treatments throughout their illness. It is essential to assess the immunization status of patients at diagnosis or, if this is not possible, at least before the beginning of immunosuppressive therapy and, subsequently, administering the appropriate vaccines. Therefore, the aim of this work is to establish clear and concise recommendations on vaccination in patients with IBD in the different settings of our clinical practice including vaccination in children, during pregnancy, breastfeeding or on trips. This consensus document emphasises the differences between inactivated and attenuated vaccines and the different degrees of immunosuppression and correlates them with the administration of both mandatory and optional vaccines recommended to our patients with IBD. Finally, as a summary, 17 recommendations are established based on the available scientific evidence and expert opinion. A multidisciplinary team with extensive experience in IBD and vaccination, made up of specialists in gastroenterology, paediatrics, nursing and pharmacy, has participated in the preparation of these recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1578-9519
dc.identifier.pmid35577225
dc.identifier.urihttps://hdl.handle.net/2445/192183
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.gastrohep.2022.03.012
dc.relation.ispartofGastroenterología y Hepatología, 2022, vol. 45, num. 10, p. 805-818
dc.relation.urihttps://doi.org/10.1016/j.gastrohep.2022.03.012
dc.rightscc by-nc-nd (c) Ferreiro Iglesias, Rocío et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationMalaltia de Crohn
dc.subject.classificationColitis ulcerosa
dc.subject.classificationVacunació
dc.subject.classificationCribratge
dc.subject.otherCrohn's disease
dc.subject.otherUlcerative colitis
dc.subject.otherVaccination
dc.subject.otherMedical screening
dc.titleRecomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre la importancia, el cribado y la vacunación en pacientes con enfermedad inflamatoria intestinal
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1-s2.0-S0210570522001406-main.pdf
Mida:
511.66 KB
Format:
Adobe Portable Document Format